Free Trial

Arxis (NASDAQ:ARXS) Reaches New 52-Week Low - Time to Sell?

Arxis logo with Manufacturing background
Image from MarketBeat Media, LLC.

Key Points

  • Shares hit a new 52-week low — ARXS traded as low as $34.44 (last at $34.70) during mid-day trading with about 353,553 shares changing hands.
  • Significant insider buying — Director Stephen Duane Oetgen bought 25,000 shares and insider Kevin Scott Perhamus bought 53,600 shares at $28 on April 17 (about $2.2M combined), and insiders have acquired 201,564 shares worth $5.64M in the past three months, increasing their respective stakes to 30,357 and 3,573,133 shares.
  • Interested in Arxis? Here are five stocks we like better.

Shares of Arxis, Inc. (NASDAQ:ARXS - Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $34.44 and last traded at $34.70, with a volume of 353553 shares trading hands. The stock had previously closed at $35.15.

Arxis Price Performance

Insider Buying and Selling at Arxis

In related news, Director Stephen Duane Oetgen purchased 25,000 shares of the business's stock in a transaction on Friday, April 17th. The stock was acquired at an average price of $28.00 per share, for a total transaction of $700,000.00. Following the purchase, the director owned 30,357 shares of the company's stock, valued at approximately $849,996. This trade represents a 466.68% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Kevin Scott Perhamus purchased 53,600 shares of the business's stock in a transaction on Friday, April 17th. The shares were bought at an average price of $28.00 per share, with a total value of $1,500,800.00. Following the purchase, the insider directly owned 3,573,133 shares in the company, valued at approximately $100,047,724. The trade was a 1.52% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have acquired 201,564 shares of company stock worth $5,643,792.

About Arxis

(Get Free Report)

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers' most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arxis Right Now?

Before you consider Arxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arxis wasn't on the list.

While Arxis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines